A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Marc Penn, MD
Summa Health System
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Huntsville, Alabama, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Clearwater, Florida, United States
- Facility name not stated
Gainesville, Florida, United States
- Facility name not stated
Tampa, Florida, United States
- Facility name not stated
Detroit, Michigan, United States
- Facility name not stated
Akron, Ohio, United States
- Facility name not stated
Pittsburgh, Pennsylvania, United States
- Facility name not stated
Salt Lake City, Utah, United States
- Facility name not stated
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2015
- Primary completion
- 30 Jun 2019
- Completion
- 31 Jan 2020
- Last update posted
- 22 Jul 2021
- Registered enrollment
- 34
- Registry id
- NCT02277613
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.